Wnt2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
.infobox.infix-protein
; Protein Name
: Wnt Family Member 2 Protein
; Gene Symbol
: WNT2
; UniProt ID
: Q9P315
; Molecular Weight
: 37 kDa
; Subcellular Localization
: Secreted, extracellular
; Protein Family
: Wnt family
The WNT2 protein (Wingless-type MMTV integration site 2 family member) is a highly conserved secreted signaling molecule critical for embryonic development, tissue patterning, and adult brain function. As a member of the Wnt protein family, WNT2 plays distinctive roles in hippocampal development, synapse formation, and cognitive function that distinguish it from other Wnt ligands [1]. In the adult nervous system, WNT2 serves as a key regulator of synaptic plasticity, memory formation, and neuronal survival. Dysregulated WNT2 signaling has been strongly implicated in Alzheimer's disease (AD), autism spectrum disorder (ASD), and schizophrenia, making it a molecule of significant therapeutic interest [2][3].
The WNT2 protein consists of 360 amino acids with characteristic Wnt family features:
| Modification | Enzyme | Functional Role |
|---|---|---|
| Signal peptide cleavage | Signal peptidase | Secretion |
| N-linked glycosylation | OST | Stability |
| Palmitoylation (Cys-104) | PORCN | Receptor binding |
| Disulfide bonds | PDI | Proper folding |
WNT2 signals through multiple receptor combinations:
| Receptor | Pathway | Functional Outcome |
|---|---|---|
| FZD5/LRP6 | Canonical | β-catenin activation |
| FZD3 | PCP | Migration, polarity |
| FZD6 | PCP | Cytoskeletal effects |
| ROR2 | Non-canonical | Calcium signaling |
WNT2 is particularly important for the hippocampus:
WNT2 regulates synapse formation through:
WNT2 is essential for cognitive function:
WNT2 alterations in AD [2:1]:
Expression Changes:
Pathogenic Mechanisms:
Therapeutic Potential:
WNT2 in ASD [3:1]:
Genetic Evidence:
Functional Deficits:
Therapeutic Approaches:
WNT2 in schizophrenia:
WNT2 in PD:
| Region | Cell Type | Level |
|---|---|---|
| Hippocampus | Pyramidal neurons | Very high |
| Cortex | Layer 2-6 neurons | High |
| Cerebellum | Purkinje cells | Moderate |
| VTA | Dopaminergic neurons | Moderate |
| SNc | Dopaminergic neurons | Low |
| Compound | Target | Status |
|---|---|---|
| Lithium | GSK3β | Approved |
| CHIR99021 | GSK3β | Preclinical |
| WNT agonists | FZD/LRP6 | Discovery |
The study of Wnt2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Wodarz A, Nusse R. Wnt signaling in development. Annu Rev Cell Dev Biol. 1998;14:59-88. PMID:9604425 ↩︎
De Ferrari GV, et al. WNT/β-catenin in AD. Mol Psychiatry. 2003;8(3):252-260. PMID:12646991 ↩︎ ↩︎
Wassink TH, et al. WNT2 and ASD. Am J Med Genet. 2001;105(6):521-527. PMID:11449396 ↩︎ ↩︎